📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: C4X Discovery

1.1 - Company Overview

C4X Discovery Logo

C4X Discovery

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of NMR-based 3D molecular structure determination to optimize drug design and development, partnering with pharma to generate better, safer products. Offers Conformetrix 4D structural design technology, 4Sight visualizer, PatientSeek for genetic patient stratification, and programs including oral α4β7 integrin inhibitors, IL-17A inhibitors (licensed to Sanofi), and NRF2 activators (licensed to AstraZeneca).

Products and services

  • Conformetrix: Engineers 4D structural drug design using experimental-data-driven models to deliver insights into drug molecule shape, conformational behavior, and physicochemical properties for optimising medicine design
  • Oral IL-17A Inhibitor Programme: Pre-clinical initiative produces oral IL-17A inhibitors, licensed to Sanofi for further development, enabling orally administered therapeutics targeting IL-17A
  • Oral NRF2 activator: Selective programme develops potent oral activators of the NRF2 pathway for inflammatory diseases, licensed to AstraZeneca for progression into partnered development

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to C4X Discovery

Zionexa Logo

Zionexa

HQ: United States Website
  • Description: Provider of in-vivo biomarkers developed and commercialized to guide targeted therapies in oncology, aiming to improve patients' pathway and quality of life.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Zionexa company profile →
Cartesian Therapeutics Logo

Cartesian Therapeutics

HQ: United States Website
  • Description: Provider of potent, safer cell therapy in and beyond oncology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cartesian Therapeutics company profile →
Azeria Therapeutics Logo

Azeria Therapeutics

HQ: United States Website
  • Description: Provider of small-molecule cancer drug development, creating a pipeline of therapies designed to selectively inhibit pioneer factors to aid treatment of breast and prostate cancer patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Azeria Therapeutics company profile →
Cellerant Therapeutics Logo

Cellerant Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage cell- and antibody-based immunotherapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cellerant Therapeutics company profile →
Aulos Bioscience Logo

Aulos Bioscience

HQ: United States Website
  • Description: Provider of cancer immuno-oncology therapeutics, including AU-007, a computationally designed human IgG1 monoclonal antibody that selectively binds to the CD25-binding portion of IL-2 to prevent immune suppression, reduce toxic side effects, and enhance immune activation against solid tumors; plus an AI discovery platform by Biolojic Design using machine learning algorithms to design specific, highly selective functional monoclonal antibodies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aulos Bioscience company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for C4X Discovery

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to C4X Discovery

2.2 - Growth funds investing in similar companies to C4X Discovery

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for C4X Discovery

4.2 - Public trading comparable groups for C4X Discovery

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to C4X Discovery

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About C4X Discovery

What does C4X Discovery do?

C4X Discovery is a provider of NMR-based 3D molecular structure determination to optimize drug design and development, partnering with pharma to generate better, safer products. Offers Conformetrix 4D structural design technology, 4Sight visualizer, PatientSeek for genetic patient stratification, and programs including oral α4β7 integrin inhibitors, IL-17A inhibitors (licensed to Sanofi), and NRF2 activators (licensed to AstraZeneca).

Who are C4X Discovery's competitors?

C4X Discovery's competitors and similar companies include Zionexa, Cartesian Therapeutics, Azeria Therapeutics, Cellerant Therapeutics, and Aulos Bioscience.

Where is C4X Discovery headquartered?

C4X Discovery is headquartered in United Kingdom.

How many employees does C4X Discovery have?

C4X Discovery has 1,000 employees 🔒.

When was C4X Discovery founded?

C4X Discovery was founded in 2010 🔒.

What sector and industry vertical is C4X Discovery in?

C4X Discovery is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for C4X Discovery

Who are the top strategic acquirers in C4X Discovery's sector and industry

Top strategic M&A buyers and acquirers in C4X Discovery's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for C4X Discovery?

Top strategic M&A buyers groups and sectors for C4X Discovery include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in C4X Discovery's sector and industry vertical

Which are the top PE firms investing in C4X Discovery's sector and industry vertical?

Top PE firms investing in C4X Discovery's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in C4X Discovery's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in C4X Discovery's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in C4X Discovery's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to C4X Discovery include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in C4X Discovery's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for C4X Discovery?

The key public trading comparables and valuation benchmarks for C4X Discovery include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for C4X Discovery for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for C4X Discovery with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in C4X Discovery's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for C4X Discovery with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in C4X Discovery's' sector and industry vertical?

Access recent funding rounds and capital raises in C4X Discovery's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for C4X Discovery

Launch login modal Launch register modal